Discover the complete list of Active Pharmaceutical Ingredients (APIs) manufactured or distributed by Celltrion Branchburg LLC. View detailed product information, certifications, and sourcing options for each API. Connect with Celltrion Branchburg LLC for compliant, high-quality pharmaceutical ingredients trusted by global clients.
Country: U.S.A.
Supplier Description: The company acquired a former Eli Lilly and Company manufacturing plant for $330 million and commenced operations in early 2026. The Branchburg site produces biosimilar medicines used for autoimmune and oncology treatments, strengthening Celltrion’s U.S. supply chain and reducing tariff exposure. The facility is planned to expand its production capacity to approximately 132,000 liters by 2030, supporting large-scale biologics manufacturing for the U.S. market
